GLAUKOS Corp Finance Lease, Right-of-Use Asset, Amortization
GLAUKOS Corp (GKOS) reported Finance Lease, Right-of-Use Asset, Amortization of $2.41 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-02-23
- GLAUKOS Corp finance lease, right-of-use asset, amortization for the quarter ending 2020-03-31 was $607.00K, a 0.00% change year-over-year.
- GLAUKOS Corp finance lease, right-of-use asset, amortization for the quarter ending 2019-12-31 was $637.00K.
- GLAUKOS Corp finance lease, right-of-use asset, amortization for the quarter ending 2019-09-30 was $593.00K.
- GLAUKOS Corp finance lease, right-of-use asset, amortization for the quarter ending 2019-06-30 was $593.00K.
- GLAUKOS Corp finance lease, right-of-use asset, amortization for fiscal 2025 was $2.41M, a 1.13% increase from fiscal 2024.
- GLAUKOS Corp finance lease, right-of-use asset, amortization for fiscal 2024 was $2.38M, a 1.49% decline from fiscal 2023.
- GLAUKOS Corp finance lease, right-of-use asset, amortization for fiscal 2023 was $2.42M, a 0.00% change from fiscal 2022.
- GLAUKOS Corp finance lease, right-of-use asset, amortization for fiscal 2022 was $2.42M, a 0.00% change from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.41M 10-K · filed 2026-02-23 | |||
| 2024-12-31 | $2.38M 10-K · filed 2026-02-23 | |||
| 2023-12-31 | $2.42M 10-K · filed 2025-02-25 | |||
| 2022-12-31 | $2.42M 10-K · filed 2024-02-23 | |||
| 2021-12-31 | $2.42M 10-K · filed 2023-02-24 | |||
| 2020-12-31 | $2.42M 10-K · filed 2022-02-28 | |||
| 2020-03-31 | $607.00K 10-Q · filed 2020-05-07 | $1.24M derived: sum of 2 quarters · filed 2021-03-01 | $1.84M derived: sum of 3 quarters · filed 2021-03-01 | $2.43M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-12-31 | $637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.23M derived: sum of 2 quarters · filed 2021-03-01 | $1.82M derived: sum of 3 quarters · filed 2021-03-01 | $1.82M 10-K · filed 2021-03-01 |
| 2019-09-30 | $593.00K 10-Q · filed 2019-11-06 | $1.19M derived: sum of 2 quarters · filed 2019-11-06 | $1.19M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $593.00K 10-Q · filed 2019-08-08 | $593.00K 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $607.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |